Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia

Table 1

Clinical parameters in subjects from four groups.

	Ctrl	NAFLD	HL	HL + NAFLD
n	24	27	26	26
Gender (male/female)	10/14	11/16	11/15	12/14
Age (years)	50.75 ± 5.68	51.00 ± 5.63	50.46 ± 5.68	50.77 ± 6.05
BMI	26.20 ± 2.80	26.48 ± 2.72	25.99 ± 2.62	26.63 ± 3.00
ALT (U/L)	15.71 ± 6.05	19.67 ± 6.16	15.12 ± 6.05	19.23 ± 8.70
AST (U/L)	21.88 ± 4.17	24.00 ± 4.13	22.08 ± 4.17	25.46 ± 7.03
TBA (μmol/L)	6.89 ± 4.01	5.46 ± 2.61	5.52 ± 4.01	5.77 ± 3.06
TC (μmol/L)	4.59 ± 0.79	4.94 ± 1.24	5.90 ± 0.79^#	5.62 ± 1.20
TG (μmol/L)	0.93 ± 0.32	1.08 ± 1.34	2.05 ± 0.32^#	2.32 ± 0.95^#
TBIL (μmol/L)	13.74 ± 2.03	14.76 ± 1.58	16.12 ± 1.67	15.26 ± 1.48
DBIL (μmol/L)	5.62 ± 1.69	5.24 ± 1.10	4.82 ± 0.74	4.8 ± 1.05
IBIL (μmol/L)	8.12 ± 1.30	9.52 ± 1.77	11.3 ± 1.37	10.46 ± 1.51
LDL-C	2.50 ± 0.60	2.93 ± 1.01	3.66 ± 0.60^#	3.58 ± 0.78^#
HDL-C	1.46 ± 0.30	1.28 ± 0.33	1.22 ± 0.30	1.19 ± 0.23

All values are expressed as mean ± SD; compared with control, ^# compared with NAFLD.